Photosensitized release of nitric oxide
11807529 · 2023-11-07
Assignee
Inventors
Cpc classification
International classification
Abstract
The invention proposes the photosensitized generation of nitric oxide (NO) from alanosine (3-(hydroxynitrosoamino)-D,L-alanine) by aluminum phthalocyanine tetrasulfonate (AlPcS4). While NO is obtained in nitrogen-saturated solutions, the invention proposes that both NO and peroxynitrite are produced in air-saturated solutions. Enhancement of NO production occurs in the presence of ubiquinone-0. The invention evidence that NO is produced by the photosensitized oxidation of alanosine. Both NO and peroxynitrite are detected during photoirradiation of AlPcS4 in the presence of 2-methyl-2-nitrosopropane (MNP) and hypoxanthine, but not in the absence of hypoxanthine, in air-saturated solutions, where HX is acting as sacrificial electron donor, thus promoting superoxide formation.
Claims
1. A method of photosensitized production of Nitride Oxide (NO) comprising: photoirradiating a solution containing 2-methyl-2-nitrosopropane (MNP) and aluminum phthalocyanine tetrasulfonate (AlPcS4) in the presence of a sacrificial electron donor compound, wherein Nitride Oxide (NO) is produced.
2. The method of claim 1, wherein said sacrificial electron donor compound is hypoxanthine (HX).
3. The method of claim 1, wherein peroxynitrite is also produced.
4. The method of claim 1, wherein said solution is either air-saturated or N2-saturated.
Description
BRIEF DESCRIPTION OF THE DAWINGS
(1) Further features and advantages of the invention will become apparent from the following detailed description taken in conjunction with the accompanying figures showing illustrative embodiments of the invention, in which:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10) Throughout the figures, the same reference numbers and characters, unless otherwise stated, are used to denote like elements, components, portions or features of the illustrated embodiments. The subject invention will be described in detail in conjunction with the accompanying figures, in view of the illustrative embodiments.
DETAILED DESCRIPTION OF THE INVENTION
Materials and Methods
Materials
(11) Alanosine (3-(hydroxynitrosoamino)-D,L-alanine,
Methods
Sample Irradiation for EPR Analysis
(12) The NO probe, carboxy-PTIO, was used to detect NO formation from the production of the carboxy-PTI EPR spectrum, as reported previously. Air- or N.sub.2-saturated samples containing AlPcS4 (with absorbance of 1 at 675 nm), alanosine (or MNP, in the presence and absence of HX), in the presence or absence of ubiquinone-0 and carboxy-PTIO in 50 mM phosphate buffer (pH 7.4) were irradiated at 675 nm in a 1 cm light path Pyrex cuvettes with continuous stirring for different periods of time. At the end of each period, samples were then transferred into N.sub.2— or air-saturated EPR flat quartz cells (60 X 10 X 0.25 mm) and placed in the EPR instrument cavity for analysis. A 1000 W xenon arc lamp coupled to a Spectral Energy GM 252 high intensity grating monochromator with a bandwidth of ± 20 nm was used as the irradiation source. EPR spectra were recorded on a Bruker ER-200D spectrometer at 100 kHz magnetic field modulation. EPR line intensities were determined from the peak-to-peak derivative amplitudes times the square of the peak-to-peak widths.
Sample Irradiation in the NO Electrode Chamber
(13) Nitric oxide production rates were monitored using a NO-specific electrochemical probe (ISO-NOP) inserted in a thermostated NO chamber (World Precision Instruments, Sarasota, FL) at 37° C. The chamber was either saturated with air or purged with high purity nitrogen followed by injection of 1.00 mL of an air- or nitrogen-saturated solution containing from 0 to 1 mM alanosine or 0 to 3 mM MNP, 10 .Math.M AlPcS4 and 0 or 500 .Math.M UBQ-0 in 50 mM phosphate buffer (pH 7.4). This was followed by immediate exclusion of all gas bubbles out of the sample, through the chamber capillary. The sample was continuously stirred using a spinning bar. Data acquisition was started before irradiation. The sample was then irradiated at 670 nm using a B&W Tek diode laser with a constant power of 255 mW. Basal voltage was calibrated to zero every day. Voltage output corresponding to a 20 .Math.M NO solution was checked every day, and the electrode membrane was replaced in case there was no agreement with previous outputs within 10%. The electrode was calibrated daily with known concentrations of NaNOz by reacting this salt with KI in sulfuric acid medium. NO production data were collected in a computer, and the initial rates of NO consumption (RNO) were measured. RNO values reported are averages of 3 determinations for each type of sample.
Peroxynitrite Formation
(14) Peroxynitrite formation was detected indirectly by its reaction with L-tyrosine to produce 3- nitrotyrosine, as described previously. For this purpose, micromolar amounts of L-tyrosine were included in the air-saturated samples to be irradiated and its nitro-substituted product detected at 274 nm using HPLC. HPLC analyses were performed using a HP Zorbax SB-C18 (4.6 x 250 mm) column and eluted with a solvent mixture of 95 % ammonium acetate (pH 4.7) and 5 % methanol. An Agilent 1100 analytical HPLC system with absorption detection at 276 nm and a flow rate of 0.8 mL/min was used. The retention times of L-tyrosine and 3-nitrotyrosine peaks were determined using commercial standards. All determinations were repeated at least three times, and the average of these determinations is reported.
Superoxide Production
(15) Superoxide production was measured using the SOD-inhibitable ferricytochrome c reduction method, as described elsewhere. Air-saturated solutions containing 0 or 1 mM HX, 10 .Math.M AlPcS4 and 50 .Math.M ferricytochrome C were irradiated at 675 nm for 10 min followed by measuring the solution absorbance at 550 nm. The latter was performed in the presence and absence of 100 U/mL of SOD. Differences in absorbances of irradiated solutions in the presence and absence of SOD correspond to the SOD-inhibitable absorbances. The latter are proportional to the superoxide concentration produced.
Results and Discussion
Photoirradiation of Alanosine-Containing Solutions
(16) Photoirradiation, at 675 nm, of a Nz-saturated sample, containing 4 mM carboxy-PTIO, 10 .Math.M AlPcS4, 500 .Math.M alanosine and 50 mM phosphate buffer (pH 7.4) produces the NO-derived carboxy-PTI EPR spectrum, as shown in
(17) Further evidence for the photosensitized production of NO was obtained by the photoirradiation of a solution containing 1 mM alanosine, 10 .Math.M AlPcS4 and 50 mM phosphate buffer (pH 7.4) under air- or N.sub.2— saturated conditions at the NO electrode chamber, as shown in
(18)
(19) TABLE-US-00001 NO source N.sub.2-saturated air-saturated RNO (.sub.I1M/s) RNO+.sub.UBQ/ RNO-.sub.UBQ alanosine X 2.03 ± 0.03 3.3 + 500 .Math.M UBQ-0 6.8 ± 0.2 X 0.12 ± 0.03 12.3 + 500 .Math.M UBQ-0 1.47 ± 0.04 MNP X 2.4 ± 0.2 1.2 + 500 .Math.M UBQ-0 2.8 ± 0.1 X 0.51 ± 0.05 1.3 + 500 .Math.M UBQ-0 0.67 ± 0.04
(20) The bimolecular rate constant for the reaction of alanosine with the excited sensitizer (k.sub.4, see
(21)
(22) where k.sub.02 and k.sub.4 are the bimolecular rate constants between the excited state of AlPcS4 and O.sub.2 and alanosine, respectively. The rate constant, k.sub.02, when the dye is AlPcS4 has been reported as 1.8 x 10.sup.9 M.sup.-1 s.sup.-1. Thus, the bimolecular rate constant k.sub.4 can be determined from the slope of the plot of 1/RNO vs. 1/[alanosine], as shown in
Photosensitized Peroxynitrite Production in Alanosine-Containing Solutions
(23) Photoirradiation of an air-saturated sample containing 10 .Math.M AlPcS4, 2.0 mM alanosine, 100 .Math.M tyrosine and 50 mM phosphate buffer (pH 7.4) produces 3-nitrotyrosine, as identified by HPLC using a commercial standard, as shown in Table 2 below indicating the amounts of 3-nitrotyrosine obtained after photolysis at 675 nm of air-saturated samples containing AlPcS4 (A=1 at 675 nm), alanosine or MNP, 100 .Math.M L-tyrosine and 50 mM phosphate buffer (pH 7.4). Errors are the standard deviations of the average of 3 determinations. The latter is indirect evidence for peroxynitrite formation as previously described. Thus, the reaction of the photosensitized generation of superoxide (O.sub.2•—) with NO produces the powerful oxidant and nitrating agent, peroxynitrite (ONOO—). Since alanosine is being photooxidized by the dye-excited state, the reduced dye is able to reduce triplet oxygen to the superoxide ion, followed by peroxynitrite formation as explained below.
(24) TABLE-US-00002 NO source Irradiation time/min [HX] / mM [3-nitrotyrosine]/ .Math.M 2 mM alanosine 10 0 5 ± 1 15 0 11± 2 20 0 16 ± 3 2 mM MNP 10 1 0 15 1 0 25 1 0.5 ± 0.1
Photoirradiation of MNP-Containing Solutions
(25) The photosensitized release of NO by MNP solutions in the presence of AlPcS4 has been previously reported and reproduced here, as indicated in
(26) In contrast to alanosine, addition of UBQ-0 to MNP-containing solutions has no significant effect on the extent of the photosensitized NO production, (Table 1), since the mechanism of NO release by MNP is not oxidation, as previously reported.
Conclusion
(27) The photosensitized production of NO from alanosine occurs under aerobic and anaerobic conditions. While the presence of UBQ-0 increases the rate of photosensitized NO production by alanosine, it has little influence on the rate of photosensitized production of NO by MNP. These observations indicate that NO is produced by the photosensitized oxidation of alanosine. In air-saturated solutions, AlPcS4 photosensitize the production of peroxynitrite from alanosine while the photosensitized production of peroxynitrite from MNP requires the presence of HX as sacrificial electron donor. This invention demonstrates that a carbon-bound diazenium diolate such as alanosine can be photosensitized to produce both NO and peroxynitrite. The photosensitized production of NO could be used in photodynamic therapies of malignancies where NO or peroxynitrite are used as the toxic agents and where nanoparticle carriers, containing both the NO source and the photosensitizer, are transported to the desired tissue.
(28) Although the present invention has been described herein with reference to the foregoing exemplary embodiment, this embodiment does not serve to limit the scope of the present invention. Accordingly, those skilled in the art to which the present invention pertains will appreciate that various modifications and equivalents are possible, without departing from the technical spirit of the present invention.